갑상선 암의 분자 진단

키워드

참고문헌 (56)

1. Nikiforov YE, "Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules", J Clin Endocrinol Metab, 94, pp.2092~2098 (2009)
2. Cooper DS, "American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer", Thyroid, 16, pp.109~142 (2006)
3. Frates MC, "Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography", J Clin Endocrinol Metab, 91, pp.3411~3417 (2006)
4. Kim DL, "High prevalence of carcinoma in ultrasonography-guided fine needle aspiration cytology of thyroid nodules", Endocr J, 55, pp.135~142 (2008)
5. Papini E, "Risk of malignancy in nonpalpable thyroid nodules:predictive value of ultrasound and color-Doppler features", J Clin Endocrinol Metab, 87, pp.1941~1946 (2002)
6. Greaves TS, "Follicular lesions of thyroid: a 5-year fine-needle aspiration experience", Cancer, 90, pp.335~341 (2000)
7. Sclabas GM, "Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients", Am J Surg, 186, pp.702~710 (2003)
8. Yassa L, "Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation", Cancer, 111, pp.508~516 (2007)
9. Baloch ZW, "Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference", Diagn Cytopathol, 36, pp.425~437 (2008)
10. Mazzaferri EL, "Management of a solitary thyroid nodule", N Engl J Med, 328, pp.553~559 (1993)
11. Baloch ZW, "Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology", Diagn Cytopathol, 26, pp.41~44 (2002)
12. Callcut RA, "The utility of frozen section evaluation for follicular thyroid lesions", Ann Surg Oncol, 11, pp.94~98 (2004)
13. Robertson ML, "Continuous laryngeal nerve integrity monitoring during thyroidectomy:does it reduce risk of injury?", Otolaryngol Head Neck Surg, 131, pp.596~600 (2004)
14. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer", Thyroid, 19, pp.1167~1214 (2009)
15. Kondo T, "Pathogenetic mechanisms in thyroid follicular-cell neoplasia", Nat Rev Cancer, 6, pp.292~306 (2006)
16. Fagin JA, "Genetics of papillary thyroid cancer initiation: implications for therapy", Trans Am Clin Climatol Assoc, 116, pp.259~271 (2005)
17. Adeniran AJ, "Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas", Am J Surg Pathol, 30, pp.216~222 (2006)
18. Kimura ET, "High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET", PTC-RASBRAF signaling pathway in papillary thyroid carcinoma, 2003, pp.63, 1454~1457
19. Soares P, "BRAF mutations and RET", PTC rearrangements are alternative events in the etiopathogenesis of PTC, 2003, pp.22, 4578~4580
20. Nikiforova MN, "RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma", J Clin Endocrinol Metab, 88, pp.2318~2326 (2003)
21. García-Rostán G, "Mutation of the PIK3CA gene in anaplastic thyroid cancer", Cancer Res, 65, pp.10199~10207 (2005)
22. Hou P, "Genetic alterations and their relationship in the phosphatidylinositol 3-kinase", Akt pathway in thyroid cancer, 2007, pp.13, 1161~1170
23. Ricarte-Filho JC, "Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1", Cancer Res, 69, pp.4885~4893 (2009)
24. de Groot JW, "RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors", Endocr Rev, 27, pp.535~560 (2006)
25. Jo YS, "Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer", J Clin Endocrinol Metab, 91, pp.3667~3670 (2006)
26. Kim TY, "The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma", Clin Endocrinol, 65, pp.364~368 (2006)
27. Huang Y, "Gene expression in papillary thyroid carcinoma reveals highly consistent profiles", Proc Natl Acad Sci U S A, 98, pp.15044~15049 (2001)
28. Franco C, "Molecular markers in thyroid fine-needle aspiration biopsy: a prospective study", Appl Immunohistochem Mol Morphol, 17, pp.211~215 (2009)
29. Hoque MO, "Quantitative assessment of promoter methylation profiles in thyroid neoplasms", J Clin Endocrinol Metab, 90, pp.4011~4018 (2005)
30. Hu S, "Detection of serum deoxyribonucleic acid methylation markers:a novel diagnostic tool for thyroid cancer", J Clin Endocrinol Metab, 91, pp.98~104 (2006)
31. Xing M, "Gene methylation in thyroid tumorigenesis", Endocrinology, 148, pp.948~953 (2007)
32. He H, "The role of microRNA genes in papillary thyroid carcinoma", Proc Natl Acad Sci U S A, 102, pp.19075~19080 (2005)
33. Nikiforova MN, "MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility", J Clin Endocrinol Metab, 93, pp.1600~1608 (2008)
34. Pallante P, "MicroRNA deregulation in human thyroid papillary carcinomas", Endocr Relat Cancer, 13, pp.497~508 (2006)
35. Nikiforova MN, "Molecular diagnostics and predictors in thyroid cancer", Thyroid, 19, pp.1351~1361 (2009)
36. Kumagai A, "Clinical implications of pre-operative rapid BRAF analysis for papillary thyroid cancer", Endocr J, 54, pp.399~405 (2007)
37. Xing M, "Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer", J Clin Endocrinol Metab, 89, pp.2867~2872 (2004)
38. Domingues R, "Searching for RET", PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma, 2005, pp.16, 27~31
39. Pizzolanti G, "Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET", PTC rearrangement, 2007, pp.17, 1109~1115
40. Sapio MR, "Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma", Endocr Relat Cancer, 14, pp.1089~1097 (2007)
41. Sapio MR, "Detection of RET", PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings, 2007, pp.66, 678~683
42. Jo YS, "Diagnostic value of pyrosequencing for the BRAF V600E mutation in ultrasound-guided fine-needle aspiration biopsy samples of thyroid incidentalomas", Clin Endocrinol, 70, pp.139~144 (2009)
43. Zatelli MC, "BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies", Eur J Endocrinol, 161, pp.467~473 (2009)
44. Jin L, "BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid", Diagn Mol Pathol, 15, pp.136~143 (2006)
45. Cohen Y, "Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules", Clin Cancer Res, 10, pp.2761~2765 (2004)
46. Salvatore G, "Analysis of BRAF point mutation and RET", PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma, 2004, pp.89, 5175~5180
47. Rowe LR, "Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules", Cytojournal, 3, pp.10~ (2006)
48. Xing M, "BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer", J Clin Oncol, 27, pp.2977~2982 (2009)
49. Marchetti I, "A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates", Thyroid, 19, pp.837~842 (2009)
50. Kim SK, "Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules", Diagn Mol Pathol, 17, pp.118~125 (2008)
51. Hayashida N, "A rapid and simple detection method for the BRAF (T1796A) mutation in fine-needle aspirated thyroid carcinoma cells", Thyroid, 14, pp.910~915 (2004)
52. Chung KW, "Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area", Clin Endocrinol, 65, pp.660~666 (2006)
53. Chou CK, "miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation", Thyroid, 20, pp.489~494 (2010)
54. Kwak JY, "Dual priming oligonucleotide-based multiplex PCR analysis for detection of BRAFV600E mutation in FNAB samples of thyroid nodules in BRAFV600E mutation-prevalent area", Head Neck, 32, pp.490~498 (2010)
55. Kim SW, "BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population", J Clin Endocrinol Metab, 95, pp.3693~3700 (2010)
56. Zhu Z, "Prevalence of RET", PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity, 2006, pp.91, 3603~3610

관련 논문AI추천